Abstract:The objectives of the present study were to investigate the effect of ANG-(1-7) on the development of cardiac hypertrophy and to identify the intracellular mechanism underlying this action of ANG-(1-7). Blood pressure and heart rate were recorded using radiotelemetry before and after chronic subcutaneous infusion of control (PBS), ANG II, ANG-(1-7), or ANG II + ANG-(1-7) for 4 wk in normotensive rats. Chronic administration of ANG-(1-7) did not affect either basal blood pressure or the ANG II-induced elevation in blood pressure. However, ANG-(1-7) significantly attenuated ANG II-induced cardiac hypertrophy and perivascular fibrosis in these rats. These effects of ANG-(1-7) were confirmed in cultured cardiomyocytes, in which ANG-(1-7) significantly attenuated ANG II-induced increases in cell size. This protective effect of ANG-(1-7) was significantly attenuated by pretreatment with A779 (a Mas receptor antagonist) or Mito-TEMPO (a mitochondria-targeting superoxide scavenger) as well as blockade of Sirt3 (a deacetylation-acting protein) by viral vector-mediated overexpression of sirtuin (Sirt)3 short hairpin (sh)RNA. Western blot analysis demonstrated that treatment with ANG-(1-7) dramatically increased Sirt3 expression. In addition, ANG-(1-7) attenuated the ANG II-induced increase in mitochondrial ROS generation, an effect that was abolished by A779 or Sirt3 shRNA. Moreover, ANG-(1-7) increased FoxO3a deacetylation and SOD2 expression, and these effects were blocked by Sirt3 shRNA. In summary, the protective effects of ANG-(1-7) on ANG II-induced cardiac hypertrophy and increased mitochondrial ROS production are mediated by elevated SOD2 expression via stimulation of Sirt3-dependent deacetylation of FoxO3a in cardiomyocytes. Thus, activation of the ANG-(1-7)/Sirt3 signaling pathway could be a novel therapeutic strategy in the management of cardiac hypertrophy and associated complications.NEW & NOTEWORTHY Chronic subcutaneous ANG-(1-7) has no effect on ANG II-induced elevations in blood pressure but significantly attenuates ANG II-induced cardiac hypertrophy and fibrosis by a mitochondrial ROS-dependent mechanism. This protective effect of ANG-(1-7) against the action of ANG II action is mediated by stimulation of sirtuin-3-mediated deacetylation of FoxO3a, which triggers SOD2 expression.

Angiotensin1-7 Protects Cardiomyocytes from Hypoxia/reoxygenation-Induced Oxidative Stress by Preventing ROS-associated Mitochondrial Dysfunction and Activating the Akt Signaling Pathway.

Cyclooxygenase mediates cardioprotection of angiotensin-(1-7) against ischemia/reperfusion-induced injury through the inhibition of oxidative stress.

Angiotensin (1-7) Alleviates Postresuscitation Myocardial Dysfunction by Suppressing Oxidative Stress Through the Phosphoinositide 3-Kinase, Protein Kinase B, and Endothelial Nitric Oxide Synthase Signaling Pathway

Angiopoietin-1 Protects H9c2 Cells from H2O2-induced Apoptosis Through AKT Signaling.

Angiotensin (1−7) prevent heart dysfunction and left ventricular remodeling caused by renal dysfunction in 5/6 nephrectomy mice

Ang (1-7) Improves Cardiac Function After Resuscitation From Cardiac Arrest

Alpha7 nicotinic acetylcholine receptor activation protects against myocardial reperfusion injury through modulation of autophagy.

Angiotensin 1–7 increases cardiac tolerance to ischemia/reperfusion and mitigates adverse remodeling of the heart—The signaling mechanism

Ginsenoside Rg1 Protects Cardiomyocytes Against Hypoxia/Reoxygenation Injury Via Activation of Nrf2/HO-1 Signaling and Inhibition of JNK

Angiotensin-(1-7) Relieved Renal Injury Induced by Chronic Intermittent Hypoxia in Rats by Reducing Inflammation, Oxidative Stress and Fibrosis

Heat Shock Transcription Factor-1 Inhibits H2O2-induced Apoptosis Via Down-Regulation of Reactive Oxygen Species in Cardiac Myocytes

Neuroprotective Effect of Angiotensin-(1-7) Against Focal Cerebral Ischemic-Reperfusion Injury in Rats

Overexpression of Vasostatin-1 Protects Hypoxia/Reoxygenation Injuries in Cardiomyocytes Independent of Endothelial Cells

Ho-1 Protects Against Hypoxia/Reoxygenation-Induced Mitochondrial Dysfunction In H9c2 Cardiomyocytes

Angiotensin II prompts heart cell apoptosis via AT1 receptor-augmented phosphatase and tensin homolog and miR-320-3p functions to enhance suppression of the IGF1R-PI3K-AKT survival pathway

Protective effect of ginsenoside Rg1 on hypoxia/reoxygenation injury and its mechanism

Protective Role Of Retinoid X Receptor In H9c2 Cardiomyocytes From Hypoxia/Reoxygenation Injury In Rats

Angiotensin-(1-7) Attenuates Angiotensin II-induced Cardiac Hypertrophy Via a Sirt3-dependent Mechanism.

Involvement of Vascular Peroxidase 1 in Angiotensin II-induced Hypertrophy of H9c2 Cells.

RXR Agonists Inhibit Oxidative Stress-Induced Apoptosis in H9c2 Rat Ventricular Cells.

Angiotensin 1-7 restrains vascular injury of extracorporeal membrane oxygenation by inhibiting ferroptosis